Comparison of the tolerability, ease of use, and efficacy of donepezil and rivastigmine in Alzheimer's disease patients: A 12-week multinational study

被引：0
|
作者：
Wilkinson, DG
Passmore, P
Smith, R
Hock, C
Potonik, F
Maud, C
Hopker, S
机构：
来源：
NEUROLOGY | 2001年 / 56卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A456 / A457
页数：2
相关论文
共 50 条
  • [1] The tolerability, ease of use and efficacy of donepezil and rivastigmine in Alzheimer's disease patients: A 12-week, multinational, comparative study
    Bullock, R
    Passmore, P
    Potocnik, F
    Hock, C
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S19 - S19
  • [2] A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease
    Wilkinson, DG
    Passmore, AP
    Bullock, R
    Hopker, SW
    Smith, R
    Potocnik, FCV
    Maud, CM
    Engelbrecht, I
    Hock, C
    Ieni, JR
    Bahra, RS
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 441 - 446
  • [3] A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease
    Jones, RW
    Soininen, H
    Hager, K
    Aarsland, D
    Passmore, P
    Murthy, A
    Zhang, R
    Bahra, R
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (01) : 58 - 67
  • [4] First head to head study comparing the tolerability, ease of use, and efficacy of donepezil and galantamine in Alzheimer's disease
    Passmore, P
    Wetterberg, P
    Adler, G
    Bullock, R
    Soininen, H
    Aarsland, D
    Murthy, A
    Zhang, R
    Bahra, R
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S97 - S97
  • [5] A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma
    Hansel, Trevor T.
    Benezet, Olivier
    Kafe, Henri
    Ponitz, Hans-Hermann
    Cheung, David
    Engelstaetter, Renate
    Barnes, Peter J.
    CLINICAL THERAPEUTICS, 2006, 28 (06) : 906 - 920
  • [6] Effectiveness and Safety of Donepezil in Hispanic Patients with Alzheimer's Disease: A 12-Week Open-Label Study
    Lopez, Oscar L.
    Mackell, Joan A.
    Sun, Yijun
    Kassalow, Laurent M.
    Xu, Yikang
    McRae, Thomas
    Li, Honglan
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (11) : 1350 - 1358
  • [7] Adding memantine to therapy with rivastigmine in patients with mild to moderate Alzheimer's disease: Results of a 12-week pilot study
    Riepe, MW
    Adler, G
    Ibach, B
    Tracik, F
    NEUROLOGY, 2005, 64 (06) : A363 - A364
  • [8] Donepezil versus rivastigmine tolerability study in dementia with Lewy bodies and Alzheimer's disease
    Magierski, R.
    Sobow, T.
    Kloszewska, I.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S62 - S62
  • [9] First head to head study comparing the tolerability and satisfaction/ease of use of donepezil and galantamine in Alzheimer's disease
    Aarsland, D
    Alhainen, K
    Bullock, R
    Wetterberg, P
    Smith, R
    Soininen, H
    Murthy, A
    Zhang, R
    Bahra, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S384 - S384
  • [10] Safety and efficacy of donepezil in a 12-week, open-label trial in African Americans with mild to moderate Alzheimer's disease
    Griffith, P
    Lichtenberg, P
    Goldman, R
    Payne-Parrish, J
    Richardson, S
    NEUROLOGY, 2005, 64 (06) : A366 - A366
12345